Does estradiol cause hair loss? It's a question many people starting or adjusting hormone replacement therapy (HRT) or gender-affirming hormone therapy ask. Estradiol, the primary form of oestrogen used in these treatments, has a complex relationship with hair biology. While it is generally considered hair-protective, hormonal fluctuations during therapy initiation or dose changes can sometimes trigger temporary shedding. This article explores how estradiol affects the hair cycle, what else might be contributing to hair loss, when to seek medical advice, and what evidence-based options are available to support hair health.

How Estradiol Affects Hair Growth and the Hair Cycle

Estradiol generally prolongs the hair growth phase and is considered hair-protective, but hormonal fluctuations during HRT initiation or dose changes can trigger temporary telogen effluvium. Hair loss is not listed as a common adverse effect in UK SmPCs for estradiol.

Experiencing these side effects? Our pharmacists can help you navigate them →

Estradiol is the primary form of oestrogen used in hormone replacement therapy (HRT) and gender-affirming hormone therapy (GAHT) in the UK. It plays a complex role in hair biology, and understanding this relationship requires a brief look at how the hair growth cycle works. Hair follicles cycle through three phases: anagen (active growth), catagen (transition), and telogen (resting and shedding). Hormones significantly influence how long follicles remain in each phase.

Oestrogen, including estradiol, is generally considered to have a hair-protective effect, partly by prolonging the anagen (growth) phase. This is why many people notice thicker, fuller hair during pregnancy, when oestrogen levels are at their highest. The mechanism by which estradiol may reduce androgen-related hair loss varies by context. Oral estradiol increases sex hormone-binding globulin (SHBG), which can reduce free androgen levels. In GAHT, estradiol combined with androgen-suppressing treatment may substantially lower circulating androgens. However, in standard menopausal HRT, estradiol does not act as a direct antiandrogen, and its protective effect on hair is more modest and variable.

When estradiol levels fluctuate — particularly during the initiation of HRT, dose changes, or the perimenopause — the shift in hormonal balance can trigger a condition called telogen effluvium. This is a temporary, diffuse form of hair shedding where a larger-than-normal proportion of hairs enter the resting phase simultaneously, leading to noticeable hair loss over weeks to months. The evidence linking HRT initiation or dose changes specifically to telogen effluvium is largely observational and based on clinical experience; postpartum and perimenopausal hormonal shifts are the more clearly recognised triggers.

Regarding adverse effects: a review of UK Summary of Product Characteristics (SmPCs) for estradiol preparations — including transdermal patches (e.g., Evorel, Estradot), gels (e.g., Oestrogel), and oral tablets (e.g., Progynova) — indicates that alopecia or hair changes are listed for some products, typically at uncommon, rare, or unknown frequency. Hair loss is not listed as a common adverse effect of estradiol in these SmPCs. Individual responses to hormonal changes vary considerably, and some people do report hair shedding when starting or adjusting estradiol therapy.^[1] This does not necessarily mean the medication is causing permanent damage to the follicles.

Not sure if this is normal? Chat with one of our pharmacists →

If you think estradiol or any other prescribed medicine may be causing hair changes, you can report this to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk.

Other Causes of Hair Loss to Consider Alongside Estradiol

Thyroid dysfunction, iron deficiency, androgenetic alopecia, and androgenic synthetic progestogens are common causes of hair loss that should be considered before attributing shedding solely to estradiol. A thorough clinical history and targeted blood tests are essential.

Before attributing hair loss solely to estradiol, it is important to consider the wide range of other conditions and factors that commonly cause or contribute to hair shedding. Hair loss is a multifactorial issue, and in many cases, estradiol may be coincidental rather than causal.

Common causes of hair loss to consider include:

• Thyroid dysfunction — both hypothyroidism and hyperthyroidism can cause diffuse hair thinning; GPs commonly consider thyroid function tests (TFTs) alongside other blood tests when assessing unexplained diffuse hair loss, based on clinical history and examination

• Iron deficiency — low ferritin is a well-recognised cause of telogen effluvium, particularly in women of reproductive age; testing and treating iron deficiency is recommended when clinically indicated

• Androgenetic alopecia — genetic pattern hair loss driven by androgen sensitivity, which can progress independently of HRT use

• Nutritional deficiencies — deficiencies in vitamin D or zinc may contribute to hair changes, though the evidence for routine testing or supplementation in the absence of clinical indicators is limited; test and treat only when deficiency is suspected. Note that high-dose biotin (vitamin B7) supplements can interfere with a range of laboratory assays, including thyroid function tests — an issue highlighted in MHRA safety guidance — and should be disclosed to your GP before blood tests are taken

• Stress and illness — significant physical or psychological stress can precipitate telogen effluvium, often with a delay of two to three months before shedding becomes apparent

• Other medications — certain drugs, including anticoagulants, retinoids, and some antidepressants, are associated with hair loss

In people taking combined HRT, it is also worth considering the progestogen component. Some synthetic progestogens (such as norethisterone or levonorgestrel) have androgenic activity and may contribute to hair thinning in susceptible individuals. Switching to a less androgenic progestogen, such as micronised progesterone (Utrogestan), is sometimes considered in clinical practice; the British Menopause Society (BMS) notes the more favourable androgenic profile of micronised progesterone compared with some synthetic progestogens, though direct evidence for improved hair outcomes specifically remains limited.

A thorough clinical history and targeted blood tests are therefore important before concluding that estradiol is responsible for hair changes.

When to Speak to a GP or Specialist About Hair Changes

See a GP if hair loss is sudden, patchy, persistent, or accompanied by other symptoms such as fatigue or scalp changes. Initial investigations typically include a full blood count, ferritin, and thyroid function tests.

Hair shedding of up to 100 strands per day is considered within the normal range. However, if you notice a significant increase in hair loss — particularly if it is persistent, patchy, or accompanied by other symptoms — it is advisable to seek medical advice. Early assessment helps identify any underlying, treatable cause.

You should contact your GP if you experience:

• Sudden or rapidly worsening hair loss

• Patchy hair loss, which may suggest alopecia areata (an autoimmune condition)

• Hair loss accompanied by fatigue, weight changes, or temperature sensitivity (possible thyroid disorder)

• Scalp changes such as redness, scaling, pain, burning, or loss of visible follicular openings — these may suggest a scarring alopecia, which warrants prompt dermatology referral

• Hair loss that begins shortly after starting, stopping, or changing the dose of estradiol or any other medication

• Significant emotional distress related to hair changes

Your GP may arrange initial investigations based on your clinical history and examination. These commonly include a full blood count (FBC), ferritin, and thyroid function tests. An androgen profile (total testosterone, SHBG, and sometimes DHEAS) is generally reserved for people with clinical signs of hyperandrogenism (such as acne, hirsutism, or irregular periods). Routine testing of LH and FSH is not usually helpful in people already taking HRT or hormonal contraception, as these will be suppressed by treatment.

In more complex cases, referral to a consultant dermatologist with a specialist interest in hair disorders may be appropriate. NHS dermatology services can assess the scalp directly, and in some cases a scalp biopsy may be recommended to clarify the diagnosis.

If you are taking estradiol as part of HRT and are concerned about hair changes, your GP or menopause specialist can review your current regimen. Adjustments to the type, dose, or delivery method of HRT may be considered. Transdermal estradiol (patches, gels, or sprays) avoids first-pass hepatic metabolism and tends to provide more consistent serum levels than oral tablets, which may suit some individuals — though a specific benefit for hair has not been established in clinical trials. Any changes to prescribed medication should always be made in consultation with a healthcare professional.

Managing Hair Loss While Taking Estradiol

Optimising your HRT regimen, correcting nutritional deficiencies such as iron and vitamin D, and considering topical minoxidil (for androgenetic alopecia) are the main evidence-informed strategies. Telogen effluvium typically resolves within six to twelve months once the underlying trigger is addressed.

If investigations confirm that hair loss is related to hormonal fluctuation or telogen effluvium rather than a separate underlying condition, there are several evidence-informed strategies that may help support hair health during estradiol therapy.

Optimising your HRT regimen is often the first step. In the UK, menopausal HRT is guided by symptom response rather than target serum oestradiol levels; routine blood monitoring of oestradiol is not recommended in standard menopause care. The aim is to use the lowest effective dose that controls symptoms. Ensuring your regimen is well-tolerated and consistent can help minimise hormonal fluctuations. If a synthetic progestogen is part of your regimen, discussing a switch to micronised progesterone with your prescriber may be worth exploring given its more favourable androgenic profile, though evidence specifically for hair outcomes remains limited.

Nutritional support plays an important role in hair health. Key considerations include:

• Iron and ferritin — iron deficiency is a treatable cause of hair shedding; your GP can check your ferritin level and advise on supplementation if deficiency is confirmed. Optimal ferritin thresholds for hair growth are debated in specialist literature and are not defined by NICE or NHS guidance; treatment decisions should be based on your results and clinical context

• Vitamin D — deficiency is common in the UK; testing and supplementation are recommended when deficiency is identified

• Protein — hair is primarily composed of keratin; adequate dietary protein supports follicle function

Topical minoxidil (available as a 2% or 5% solution or foam, without prescription in the UK) is licensed for androgenetic (hereditary) hair loss and has the strongest evidence base for this indication. Its use in telogen effluvium is off-label and the evidence is limited; it is not a licensed treatment for TE. If you are considering minoxidil, it is worth discussing this with your GP or a dermatologist first. Key practical points include: an initial increase in shedding can occur in the first few weeks of use; local scalp irritation is possible; results require consistent, long-term use to be maintained; and it should not be used during pregnancy or breastfeeding. Refer to the product information for full guidance.

Finally, gentle hair care practices — avoiding excessive heat styling, tight hairstyles, and harsh chemical treatments — can reduce mechanical hair loss and breakage. Whilst these measures will not address the hormonal root cause, they help protect existing hair during a period of increased vulnerability. Patience is also important: telogen effluvium typically resolves within six to twelve months once the underlying trigger is addressed.

Frequently Asked Questions